Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Hypertension2364 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A52724 | 22820893 | Endocrine | Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus. | 2012 | Details |
| A52728 | 22767263 | Hepatology | Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study. | 2012 | Details |
| A52748 | 22484021 | Prostaglandins Other Lipid Mediat | The functional variant V433M of the CYP4F2 and the metabolic syndrome in Swedes. | 2012 | Details |
| A52749 | 22481453 | Ann Hepatol | Serum adipocyte fatty acid binding protein in liver transplant recipients and the metabolic syndrome. | 2012 | Details |
| A52760 | 22351884 | Pediatrics | Toward a unifying hypothesis of metabolic syndrome. | 2012 | Details |
| A52768 | 22276255 | Indian J Endocrinol Metab | Metabolic syndrome in the Mediterranean region: Current status. | 2012 | Details |
| A52774 | 22185842 | Am J Physiol Endocrinol Metab | Generation and characterization of a mouse model of the metabolic syndrome: apolipoprotein E and aromatase double knockout mice. | 2011 | Details |
| A52776 | 22158268 | Int J Obes (Lond) | Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. | 2011 | Details |
| A52778 | 22074439 | Curr Pharm Des | Evaluation of the possible contribution of antioxidants administration in metabolic syndrome. | 2011 | Details |
| A52791 | 21892913 | Clin Chem Lab Med | New insights into adipose tissue dysfunction in insulin resistance. | 2011 | Details |
| A52799 | 21755605 | Wiley Interdiscip Rev Syst Biol Med | Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. | 2011 | Details |
| A52842 | 20965707 | Exp Toxicol Pathol | Diet modification and its influence on metabolic and related pathological alterations in the SHR/NDmcr-cp rat, an animal model of the metabolic syndrome. | 2010 | Details |
| A52846 | 20832799 | Atherosclerosis | High-fat diet without excess calories induces metabolic disorders and enhances atherosclerosis in rabbits. | 2010 | Details |
| A52848 | 20725711 | J Mol Med (Berl) | Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. | 2010 | Details |
| A52854 | 20649581 | Br J Pharmacol | Irbesartan treatment up-regulates hepatic expression of PPARalpha and its target genes in obese Koletsky (fa(k)/fa(k)) rats: a link to amelioration of hypertriglyceridaemia. | 2010 | Details |
| A52874 | 20361178 | Diabetologia | Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. | 2010 | Details |
| A52876 | 20336705 | Hepatology | Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. | 2010 | Details |
| A52886 | 20021538 | J Clin Hypertens (Greenwich) | Pathogenesis and pathophysiology of the cardiometabolic syndrome. | 2009 | Details |
| A52896 | 19850541 | An Pediatr (Barc) | [Fatty liver disease, insulin resistance and adiponectin in an obese pediatric population]. | 2009 | Details |
| A52913 | 19631025 | Br J Nutr | Experimental rat models to study the metabolic syndrome. | 2009 | Details |
| A52924 | 19486279 | J Viral Hepat | Hepatitis C virus infection is a risk factor for gallstone disease: a prospective hospital-based study of patients with chronic viral C hepatitis. | 2009 | Details |
| A52932 | 19358089 | Exp Clin Endocrinol Diabetes | Adipose tissue dysfunction in obesity. | 2009 | Details |
| A52938 | 19275651 | Curr Pharm Des | Renal protective effect of metabolic therapy in patients with coronary artery disease and diabetes: from bench to bed side. | 2009 | Details |
| A52948 | 20300478 | PPAR Res | PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease. | 2010 | Details |
| A52961 | 18773755 | G Ital Cardiol (Rome) | [Pharmacological therapy of obesity]. | 2008 | Details |
| A52966 | 18690758 | Am J Cardiovasc Drugs | Therapeutic effects of fibrates in postprandial lipemia. | 2008 | Details |
| A52973 | 18548089 | J Hum Hypertens | Hypertension as part of the metabolic syndrome. | 2008 | Details |
| A52981 | 18416473 | World J Gastroenterol | Alcohol consumption and metabolic syndrome among Shanghai adults: a randomized multistage stratified cluster sampling investigation. | 2008 | Details |
| A52982 | 18366118 | Hepatology | Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection. | 2008 | Details |
| A52987 | 18230901 | Front Horm Res | 11beta-hydroxysteroid dehydrogenase type 1 and obesity. | 2008 | Details |
| A52990 | 18220654 | Curr Diabetes Rev | Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. | 2007 | Details |
| A52991 | 18185059 | Curr Opin Endocrinol Diabetes Obes | Metabolic complications of obesity in childhood and adolescence: more than just diabetes. | 2008 | Details |
| A52997 | 18154189 | Clin Cornerstone | Metabolic consequences of hyperglycemia and insulin resistance. | 2007 | Details |
| A53000 | 17999758 | Theor Biol Med Model | Inflammation: a way to understanding the evolution of portal hypertension. | 2007 | Details |
| A53004 | 19124394 | Ther Adv Cardiovasc Dis | Genetics of the cardiometabolic syndrome: new insights and therapeutic implications. | 2007 | Details |
| A53005 | 17901224 | Endocrinology | Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. | 2007 | Details |
| A53006 | 17855068 | J Nutr Biochem | Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. | 2007 | Details |
| A53011 | 17573948 | Hepatol Res | Clinical significance of fatty liver associated with metabolic syndrome. | 2007 | Details |
| A53016 | 17344575 | Postgrad Med J | Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China. | 2007 | Details |
| A53017 | 17320517 | Am J Med | Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. | 2007 | Details |
| A53018 | 17296343 | Am J Med | Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. | 2007 | Details |
| A53025 | 17122751 | Panminerva Med | Metabolic syndrome and renal failure: similarities and differences. | 2006 | Details |
| A53026 | 17111296 | Horm Metab Res | Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1). | 2006 | Details |
| A53032 | 16956601 | Clin Chim Acta | Molecular mechanisms of insulin resistance and associated diseases. | 2006 | Details |
| A53035 | 16877964 | J Hypertens | Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. | 2006 | Details |
| A53052 | 16446448 | Proc Natl Acad Sci U S A | The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase. | 2006 | Details |
| A53061 | 16170675 | Herz | [Metabolic syndrome and hyperlipidemia in HIV-positive patients]. | 2005 | Details |
| A53068 | 15809359 | Hypertension | A new transgenic rat model of hepatic steatosis and the metabolic syndrome. | 2005 | Details |
| A53072 | 15687414 | Obes Res | Pathophysiology and long-term management of the metabolic syndrome. | 2004 | Details |
| A53075 | 15589689 | Biochimie | Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver. | 2004 | Details |
| A53083 | 15329185 | Obes Surg | Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. | 2004 | Details |
| A53087 | 15181027 | J Clin Endocrinol Metab | Medical consequences of obesity. | 2004 | Details |
| A53090 | 15157941 | J Nutr Biochem | Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome. | 2004 | Details |
| A53092 | 15083594 | Curr Opin Investig Drugs | Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome. | 2004 | Details |
| A53099 | 14728015 | Am J Cardiovasc Drugs | Drug treatment of combined hyperlipidemia. | 2001 | Details |
| A53100 | 14717339 | Hypertens Res | Effects of radiation on fatty liver and metabolic coronary risk factors among atomic bomb survivors in Nagasaki. | 2003 | Details |
| A53101 | 14683458 | Curr Drug Targets Immune Endocr Metabol Disord | Stearoyl-CoA desaturase-1 and the metabolic syndrome. | 2003 | Details |
| A53103 | 14577612 | Mol Cell Biochem | Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats. | 2003 | Details |
| A53136 | 10905124 | Ital Heart J | [Ischemic cardiopathy: risk factors and their biological role]. | 2000 | Details |
| A53139 | 10842668 | Ann N Y Acad Sci | Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X. | 1999 | Details |
| A53147 | 10321453 | Blood Press Suppl | Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats. | 1998 | Details |
| A53166 | 8492707 | Metabolism | Body fat topography as an independent predictor of fatty liver. | 1993 | Details |
| A53172 | 1773700 | Diabetes Care | Metabolic implications of body fat distribution. | 1991 | Details |
| A53191 | 861167 | Br J Exp Pathol | Alloxan diabetes in spontaneously hypertensive rats: gravimetric, metabolic and histopathological alterations. | 1977 | Details |